View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

CVS Health Corporation: Update to credit analysis following downgrade ...

Our credit view of this issuer reflects its execution risk related to expansion into primary care and its regulatory uncertainty related to PBM and pharmacy business practices.

Pierre FerraguÊ
  • Pierre FerraguÊ

Bible 3Q24 – Industrials: Bouncing Along the Bottom; Glimpses of a 20...

Today, we are publishing the Industrial section our 25th Tech Infrastructure Quarterly Bible. The Tech Bible is a must-read for any tech investor, as it summarizes the quarterly earnings reports from the over 140 companies we track, providing an update on our key perspectives and convictions. Industrial semi revenues were again below seasonality in 3Q24, and most companies have guided for a further decline in 4Q24. Visibility on a 2025 recovery remains limited, although Analog Devices remains p...

Moody's Ratings downgrades CVS Health to Baa3; outlook stable

Moody's Ratings (Moody's) downgraded the ratings of CVS Health Corporation (CVS) including the senior unsecured notes to Baa3 from Baa2; the senior unsecured shelf to (P)Baa3 from (P)Baa2, the junior subordinated notes to Ba1 from Baa3 and the senior unsecured commercial paper rating to Prime-3 from...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: December 14, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

 PRESS RELEASE

Altria Declares Regular Quarterly Dividend of $1.02 Per Share

RICHMOND, Va.--(BUSINESS WIRE)-- Altria Group, Inc. (NYSE: MO) today announced that our Board of Directors declared a regular quarterly dividend of $1.02 per share, payable on January 10, 2025 to shareholders of record as of December 26, 2024. The ex-dividend date is December 26, 2024. View source version on businesswire.com:

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: December 10, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

EXL named a Leader in ISG Provider Lens™ Generative AI Services Report

EXL named a Leader in ISG Provider Lens™ Generative AI Services Report NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data analytics and digital operations and solutions company, announced that it has been named a Leader in the ISG Provider Lens™ Generative AI (GenAI) Services 2024 report. The report evaluates GenAI service providers in two categories: Strategy and Consulting and Development and Deployment Services. EXL was named a Leader in both categories thanks to its success helping enterprise leaders make informed buying decisions and maximize their techno...

 PRESS RELEASE

EXL recognized as Market Leader in HFS Horizons AADA Quadfecta Service...

EXL recognized as Market Leader in HFS Horizons AADA Quadfecta Services for the Generative Enterprise, 2024 study NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data analytics and digital operations and solutions company, announced that it has been recognized as a Market Leader in the HFS Research 2024 AADA Quadfecta Services for the Generative Enterprise™, 2024 study. The study, in its inaugural edition, evaluated 27 leading analytics, AI, data platforms, and automation (AADA) service providers on their ability to unlock deep insights from their data, automate...

Pierre FerraguÊ
  • Pierre FerraguÊ

Bible 3Q24 – Autos: weakness across the board. We still expect a rebo...

Today, we are publishing the automotive section of our 25th Tech Infrastructure Quarterly Bible. The Tech Bible is a must-read for any tech investor, as it summarizes the quarterly earnings reports from the over 140 companies we track, providing an update on our key perspectives and convictions. In the coming weeks we will publish sections on Cloud Infrastructure, Telecom Equipment, Industrials, Enterprise IT, Ride sharing & Delivery, and Foundry. Automotive demand has slowed in the West, leadi...

Moody's Ratings assigns Baa3 rating to CVS' jr. subordinated notes, on...

Moody's Ratings (Moody's) assigned a Baa3 rating to CVS Health Corporation's (CVS) proposed offering of junior subordinated notes, with this rating immediately placed on review for downgrade. There are no changes to CVS' existing ratings including the Baa2 senior unsecured notes, (P)Baa2 senior unse...

Generac Holdings Inc: 1 director

A director at Generac Holdings Inc sold 4,332 shares at 193.070USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

Boston Scientific Corp: 1 director

A director at Boston Scientific Corp sold/sold after exercising options 14,010 shares at 89.269USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dire...

Booz Allen Hamilton Holding Corp: 1 director

A director at Booz Allen Hamilton Holding Corp bought 2,000 shares at 147.130USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...

Boston Scientific Corporation: Update to credit analysis following out...

Our credit view of this issuer reflects its leading position in key markets and its broad product and geographic diversification, against its ongoing appetite for acquisitions

 PRESS RELEASE

EXL to transform customer service operations with data and analytics f...

EXL to transform customer service operations with data and analytics for the Data Communications Company Strengthening smart meter infrastructure and enabling smooth customer transitions between suppliers NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data analytics, digital operations, and solutions company, has been awarded a contract to manage the service desk operations for the Data Communications Company (DCC). This role involves overseeing incidents related to smart meter infrastructure, and handling issues arising from smart meters or from consumers swi...

ExlService Holdings Inc: 1 director

A director at ExlService Holdings Inc sold 100,000 shares at 45.310USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch